Combination Therapy for Chronic Lymphocytic Leukemia (CLL)
Description
This figure template "Combination Therapy for Chronic Lymphocytic Leukemia (CLL)" is assembled using dynamic BioRender assets (icons, lines, shapes and/or text) and is fully editable.
To customize your own personalized figure using this template as a starting point, click "Use Template".
Acknowledgements
References
Mhibik, M., Gaglione, E. M., Eik, D., Herrick, J., Le, J., Ahn, I. E., ... & Wiestner, A. (2023). Cytotoxicity of the CD3× CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting. Blood Advances, 7(15), 4089-4101.
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
![example of using the icon library](https://cdn.prod.website-files.com/621e6f1effebfe03881da9bd/64c7c0fc322ef8c15744f235_ezgif.com-video-to-gif%20(1).gif)